Clinical trial

Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer

NCT02423928

Study summary

ClinicalTrials.gov

Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention Dendritic cell based cryoimmunotherapy Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cyclophosphamide Normalized identity: cyclophosphamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record ipilimumab Normalized identity: ipilimumab View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-05-01

PhasePHASE1

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Dendritic cell based cryoimmunotherapyBIOLOGICAL

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

ipilimumabDRUG · verified · RxNorm: ipilimumab

Sponsors & collaborators

Alden Cancer Therapy IIlead sponsor

Haukeland University Hospitalcollaborator

Norwegian Radium Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02423928 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.